E.GoricarK.Kores PlesnicarB.Plemenitas IljesA.DolzanV
And Type 2 Diabetes was an area whose work was led by pharmas much more than biotechs - any biotechs working on it would partner early on with pharma given the following: T2D trials are notoriously large and lengthy, so its valuable for pharma to subsidize that cost T2D drugs will likely need the help of pharma for commercial launch anyways, so partnership is inevitable Its no wonder that the first drug of biotech, Humalin, was partnered with Eli Lilly
This is just like that rival, it started as a diabetes treatment but became famous for weight loss
Substantial Weight Loss Up to 22.5% total body weight reduction in clinical trials (average 5060 lbs)
Medications work best as part of comprehensive weight management programs, not as isolated interventions
We schedule regular check-ins to monitor progress, adjust dosing, address side effects, and refine your nutrition plan